⬅ # 408 Magdalena Martullo-Blocher|# 410 John Grayken ➡

# 409 Jung-jin Seo 

$7.07B

Real Time Net Worth
as of 7/1/2024
$378.2M (5.35%)

# 409 Jung-jin Seo 

$7.07B

Real Time Net Worth
as of 7/1/2024
$378.2M (5.35%)
OccupationCofounder and Chair, Celltrion
Source of WealthBiotech
Age66
ResidenceSeoul, South Korea
Marital StatusMarried
Children2
EducationBS, Konkuk University; MS, Konkuk University
Age-Adjusted Net Worth$4.71B
Jung-jin Seo
Jung-jin Seo
South Korea
Net worth: $7.07B

Self-Made Score 

Wealth History

Hover or tap to reveal net worth by year
Loading Chart

Biography

Biographical Information

Jung-jin Seo is the founder and Chairman of Celltrion Group, a leading Korean biopharmaceutical company.
He was born in Cheongju, South Korea.
Seo graduated from Konkuk University with a degree in industrial engineering.
Before founding Celltrion, Seo built his career at Samsung Electro-Mechanics, Korea Productivity Center, and Daewoo Motors.
In 1999, Seo founded Nexol Biotech, which later became Celltrion.
Seo started Celltrion Inc. in 2002 and took it public in 2008.

Professional Career

Seo established Nexol Biotech, later known as Celltrion, after a career at various notable companies including Samsung Electro-Mechanics and Daewoo Motors.
Celltrion, founded in 2002, specializes in the research and development of various biologics, particularly monoclonal antibody therapies.
Under Seo's leadership, Celltrion achieved significant milestones such as gaining approval from EMA and FDA for Remsima®, the world's first monoclonal antibody biosimilar.
Seo's leadership has positioned Celltrion as a leader in biosimilar medications for cancer, influenza, and rheumatoid arthritis.
In March 2023, Seo returned as chairman of Celltrion group after a two-year hiatus and pledged major acquisitions.
Seo's eldest son Jin-seok co-chairs Celltrion Inc.

Company History

Celltrion, Inc. was founded in 2002 as a biopharmaceutical company, with its headquarters in Incheon, South Korea.
Originally founded as Nexol, Inc. in 1999, the company transitioned into the biopharmaceutical sector and later became Celltrion.
Over the years, Celltrion expanded its global distribution channels, reaching markets in America, Oceania, Europe, Japan, CIS, Eastern Europe, and the Middle East.
The company's products are manufactured at facilities compliant with FDA’s cGMP and the European Medicines Agency’s GMP standards.
Key products include Remsima, Herzuma, and Truxima, which are biosimilar monoclonal antibodies used in the treatment of various diseases including cancer and autoimmune disorders.

How long would it take you to become as rich as Jung-jin Seo?

If you started with $10,000 and invested an additional $500 each month at a 44.06% CAGR, it would take you 5 years to reach Jung-jin Seo's net worth of $7.07B.

Is this realistic? It depends how closely the VIX-TA-Macro Advanced model performs to its history in the future. Since Grizzly Bulls launched on January 1, 2022, it's returned 48.24% compared to 16.19% for the S&P 500 benchmark.

Enter data in all but one field below, then calculate the missing value

Jung-jin Seo is very wealthy, but what's stopping you from reaching that same level of success? As summarized in our five fundamental rules to wealth building, becoming wealthy in a modern capitalist economy is not complicated. There's actually only three variables:

  1. Your starting capital
  2. Your earnings after expenses
  3. The compound annual growth rate (CAGR) of your savings

Most people start with zero or very little, so if you weren't born into wealth, don't fret! The majority of the fortunate folks listed in our Grizzly Bulls’ Billionaires Index came from middle class or lower backgrounds. The most distinguishing characteristic of the group is their ability to consistently earn a high CAGR on their savings.

Every billionaire has a unique strategy to achieve high CAGR. For Jung-jin Seo, Biotech is the primary source. Whether you choose to invest your savings in your own businesses or the businesses of others is not as important. The salient piece of the puzzle is ensuring that your hard-earned savings are generating sufficient CAGR to reach your long term goals.

Most people simply invest their money in index funds and call it a day. There's nothing wrong with this approach, but it guarantees relative mediocrity. To achieve greatness, you need to invest your money to earn higher than average returns. In the long run, better investors will always finish ahead of better earners.

Source: Grizzly Bulls reporting

Methodology: Grizzly Bulls' Billionaires Index is a daily ranking of the world's billionaires and richest people. Grizzly Bulls strives to provide the most accurate net worth calculations available. We pull data from public equity markets, SEC filings, public real estate records, and other reputable sources.

The index is dynamic and updates daily at the close of U.S. stock market trading based on changes in the markets, economy, and updates to Grizzly Bulls' proprietary algorithm of personal wealth calculation. Stakes in public companies are tracked daily based on the relevant closing prices of the underlying securities. Additionally, stakes in private companies, cash, real estate, and other less easily valued assets are updated periodically through careful analysis of insider transactions, comparable public company sales / EBITDA multiples, etc.

Edited by: Lee Bailey